{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Processa Pharmaceuticals, Inc."},"Symbol":{"label":"Symbol","value":"PCSA"},"Address":{"label":"Address","value":"7380 COCA COLA DRIVE,SUITE 106, HANOVER, Maryland, 21076, United States"},"Phone":{"label":"Phone","value":"+1 443 776-3133"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Processa Pharmaceuticals Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on the development of drug products that are intended to improve the survival and quality of life for patients who have an unmet medical need. The company's lead product, PCS499 is an oral tablet that is an analog of an active metabolite of an already approved drug. It focuses on fibrotic related diseases such as focal segmental glomerulosclerosis, idiopathic pulmonary fibrosis. Its pipeline products comprise PCS6422, PCS12852, and PCS100."},"CompanyUrl":{"label":"Company Url","value":"https://www.processapharmaceuticals.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"David Young","title":"Director, President-Research & Development"},{"name":"George K. Ng","title":"Chief Executive Officer & Director"},{"name":"Smythe-Pinkerton Shanique","title":"Director-Clinical Operations"},{"name":"Steven Cha","title":"Senior Vice President-Clinical Research"},{"name":"Weifei Ye","title":"Senior Director-Medical & Clinical Development"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}